Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Archives of Craniofacial Surgery
>
2021
>
22
>
3
Volume:
22
Issue:
3
1. Giant basal cell carcinoma of the left lateral neck
Page:173—176
2. Delayed rupture of a posttraumatic retromaxillary pseudoaneurysm causing massive bleeding: a case report
Page:168—172
3. Reconstruction of a small defect of the lower vermilion adjacent to white roll using a modified O-Z flap
Page:164—167
4. Correction of a nasal soft triangle deficiency as a complication of augmentation rhinoplasty
Page:161—163
5. Scalp metastasis of advanced gastric cancer
Page:157—160
6. Poroid hidradenoma of the scalp
Page:154—156
7. Three-dimensional analysis of facial asymmetry after zygomaticomaxillary complex fracture reduction: a retrospective analysis of 101 East Asian patients
Page:148—153
8. Clinical assessment and management of auricular arteriovenous malformation: retrospective study
Page:141—147
9. Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?
Page:135—140
10. Treatment of Morbihan disease
Page:131—134
11. Giant basal cell carcinoma of the left lateral neck
Page:173—176
12. Delayed rupture of a posttraumatic retromaxillary pseudoaneurysm causing massive bleeding: a case report
Page:168—172
13. Reconstruction of a small defect of the lower vermilion adjacent to white roll using a modified O-Z flap
Page:164—167
14. Correction of a nasal soft triangle deficiency as a complication of augmentation rhinoplasty
Page:161—163
15. Scalp metastasis of advanced gastric cancer
Page:157—160
16. Poroid hidradenoma of the scalp
Page:154—156
17. Three-dimensional analysis of facial asymmetry after zygomaticomaxillary complex fracture reduction: a retrospective analysis of 101 East Asian patients
Page:148—153
18. Clinical assessment and management of auricular arteriovenous malformation: retrospective study
Page:141—147
19. Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?
Page:135—140
20. Treatment of Morbihan disease
Page:131—134